Did The Senate Hit Snooze On Cannabis Banking Reform? Report Indicates It Will Be Pushed To September

It was another lazy summer session for cannabis stocks when Don Murphy tweeted…

…that Senator Sherrod Brown (D-OH), who is the Chairman of the Senate Banking, Housing & Urban Affairs Committee, told him that every hopeful cannabis investor, all of the despondent social equity applicants and especially all of the operators of all-cash businesses who put their life at risk daily should effectively fuck off and die.

OK, he didn’t actually say that as much as he seemingly confirmed suspicions that the Senate will run out of time to make meaningful strides on cannabis banking before we—I mean, they—take an August-long recess, which they most-assuredly deserve after all the hard work they’ve done on behalf of their ~334 million satisfied constituents.

If this is true, we can blame Silicon Valley Bank (pushed everything by a month); or point fingers at the Senate Majority Leader (who just called this a priority); or we can blame ourselves—again—for taking our elected leaders at their word that they would provide this most basic service for something that 91% of Americans fully support.

Of course, this isn’t a referendum on SAFE itself, as much as the timing thereof—the votes are still there, and we wouldn’t be surprised to see a filibuster-proofing ninth GOP senator soon emerge to co-sponsor the bill—but patience trades at a premium 890 days after the top and an already simmering sentiment seems set to boil over.

[note: I asked an in-the-know pal if it’s possible, after what happened in December, that the Dems are slow-walking this into next week for maximum Hero splash; the response was, “it’s unlikely but possible; mark-up will likely be after recess,” adding that several other potentially positive DC developments were already in motion].

The space, staying true to the path of maximum frustration, swiftly lost 5% as towels were tossed and the NASDAQ got sold, only to reverse late in the session, led by some of the larger players. The MSOS ETF MSOS finished 1.6% lower—.09 as those things go— on ~$41 million plant-touching notional volume. Just another day in the simulation.

In other sector happenings, new reports suggest mental health treatment admissions have fallen in states that legalize marijuana, several studies have indicated cannabis possesses opioid-sparing properties post-surgery, CBD is a safe/ effective therapeutic option for seizures (this we knew) and 2.7 million New Yorkers consumed cannabis last month— just imagine if there was a viable legal framework in place!

CB1 has positions in / advises some of the companies mentioned and nothing contained herein should be considered advice.

The Benzinga Cannabis Capital Conference, the place where deals get done, is returning to Chicago this Sept 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.

Photo by Michal Matlon on Unsplash

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.